» Articles » PMID: 26826284

Harnessing the Knowledge of Animal Toxins to Generate Drugs

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2016 Jan 31
PMID 26826284
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Animal toxins present high selectivity and specificity for their molecular targets, and have long been considered as prototypes for developing novel drugs, with some successful cases. In this regard, the variety of molecules found in animal venoms, which can be capable of affecting vital physiological systems, have providing the development of studies focusing on turning those molecules (toxins) into therapeutics to treat several diseases, such as chronic pain, hypertension, thrombosis, cancer, and so on. However, some important issues have been responsible for disrupting the toxin-based drug discovery projects. In this review, we have briefly highlighted the development of drugs based on animal toxins, discussing some successful cases as well as the main causes of failure, pointing out the recent strategies applied to overcome the difficulties related to the translational process in this kind of development scenario.

Citing Articles

A Snake Toxin Derivative for Treatment of Hyponatremia and Polycystic Kidney Diseases.

Stanajic-Petrovic G, Keck M, Barbe P, Urman A, Correia E, Isnard P J Am Soc Nephrol. 2024; 36(2):181-192.

PMID: 39431458 PMC: 11801765. DOI: 10.1681/ASN.0000000505.


Crotoxin induces cytotoxic effects in human malignant melanoma cells in both native and detoxified forms.

Almeida T, Giannotti K, Ribeiro Silva L, Marques-Porto R, DeOcesano-Pereira C, Camargo L Front Pharmacol. 2024; 15:1425446.

PMID: 39114354 PMC: 11303296. DOI: 10.3389/fphar.2024.1425446.


Diversity and Evolutionary Analysis of Venom Insulin Derived from Cone Snails.

Guo Q, Huang M, Li M, Chen J, Cheng S, Ma L Toxins (Basel). 2024; 16(1).

PMID: 38251250 PMC: 10819828. DOI: 10.3390/toxins16010034.


Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom.

Galante P, Campos G, Moser J, Martins D, Dos Santos Cabrera M, Rangel M Sci Rep. 2023; 13(1):12491.

PMID: 37528129 PMC: 10393941. DOI: 10.1038/s41598-023-38828-w.


A new class of peptides from wasp venom: a pathway to antiepileptic/neuroprotective drugs.

Mortari M, Cunha A, Dos Anjos L, Amaral H, Quintanilha M, Gelfuso E Brain Commun. 2023; 5(1):fcad016.

PMID: 36844150 PMC: 9945850. DOI: 10.1093/braincomms/fcad016.